Pure Global

Injection of Hyaluronic Acid Versus Corticosteroid for Treatment of Trigger Finger - Trial NCT04645303

Access comprehensive clinical trial information for NCT04645303 through Pure Global AI's free database. This Early Phase 1 trial is sponsored by Dubai Health Authority and is currently Recruiting. The study focuses on Trigger Finger. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT04645303
Early Phase 1
Recruiting
drug
Trial Details
ClinicalTrials.gov • NCT04645303
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Injection of Hyaluronic Acid Versus Corticosteroid for Treatment of Trigger Finger
Ultrasound-Guided Injection of Hyaluronic Acid Versus Corticosteroid for Treatment of Trigger Finger: Randomized Controlled Study

Study Focus

Trigger Finger

hyaluronic acid (20 mg/2 mL)

Interventional

drug

Sponsor & Location

Dubai Health Authority

Dubai, United Arab Emirates

Timeline & Enrollment

Early Phase 1

Nov 06, 2020

Jun 04, 2021

100 participants

Primary Outcome

Change in Quinnell trigger finger grading system:

Summary

The aim of the study is to compare the therapeutic effects of hyaluronic acid versus steroid
 injections in treating trigger fingers using ultrasound guidance

ICD-10 Classifications

Trigger finger
Accessory finger(s)
Fused fingers
Accessory thumb(s)
Clubbing of fingers

Data Source

ClinicalTrials.gov

NCT04645303

Non-Device Trial